Citigroup upgraded Calithera Biosciences Inc. (Nasdaq: CALA) from a Neutral rating to a Buy rating lifting the stock price $1.15 to close at $8.10.
Cala Biosciences upgraded
February 16, 2018 at 19:15 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.